These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 20530411)
41. Adenovirus-mediated calponin h1 gene therapy directed against peritoneal dissemination of ovarian cancer: bifunctional therapeutic effects on peritoneal cell layer and cancer cells. Ogura T; Kobayashi H; Ueoka Y; Okugawa K; Kato K; Hirakawa T; Hashimoto S; Taniguchi S; Wake N; Nakano H Clin Cancer Res; 2006 Sep; 12(17):5216-23. PubMed ID: 16951241 [TBL] [Abstract][Full Text] [Related]
42. The CH-domain of calponin does not determine the modes of calponin binding to F-actin. Galkin VE; Orlova A; Fattoum A; Walsh MP; Egelman EH J Mol Biol; 2006 Jun; 359(2):478-85. PubMed ID: 16626733 [TBL] [Abstract][Full Text] [Related]
43. Expressing functional domains of mouse calponin: involvement of the region around alanine 145 in the actomyosin ATPase inhibitory activity of calponin. el-Mezgueldi M; Strasser P; Fattoum A; Gimona M Biochemistry; 1996 Mar; 35(12):3654-61. PubMed ID: 8619984 [TBL] [Abstract][Full Text] [Related]
44. Calponin h1-S175T point mutation enhances resistance to actin cytoskeleton perturbation in human cancer cells. Sugaya A; Takeoka M; Itano N; Taguchi A; Ehara T; Taniguchi S Anticancer Res; 2010 Apr; 30(4):1071-8. PubMed ID: 20530411 [TBL] [Abstract][Full Text] [Related]